Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease.
Parkinson’s disease
arterial spin labeling
cerebral blood flow
cerebrovascular reactivity
Journal
Therapeutic advances in neurological disorders
ISSN: 1756-2856
Titre abrégé: Ther Adv Neurol Disord
Pays: England
ID NLM: 101480242
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
11
2018
accepted:
02
02
2019
entrez:
30
3
2019
pubmed:
30
3
2019
medline:
30
3
2019
Statut:
epublish
Résumé
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is mainly characterized by movement dysfunction. Neurovascular unit (NVU) disruption has been proposed to be involved in the disease, but its role in PD neurodegenerative mechanisms is still unclear. The aim of this study was to investigate cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) within the regions belonging to the motor network, in patients with mild to moderate stages of PD. Twenty-eight PD patients (66.6 ± 8.6 years, 22 males, median [interquartile range, IQR] Hoehn & Yahr = 1.5 [1-1.9]) and 32 age- and sex-matched healthy controls (HCs) were scanned with arterial spin labeling (ASL) magnetic resonance imaging (MRI) for CBF assessment. ASL MRI was also acquired in hypercapnic conditions to induce vasodilation and subsequently allow for CVR measurement in a subgroup of 13 PD patients and 13 HCs. Median CBF and CVR were extracted from cortical and subcortical regions belonging to the motor network and compared between PD patients and HCs. In addition, the correlation between these parameters and the severity of PD motor symptoms [quantified with Unified Parkinson's Disease Rating Scale part III (UPDRS III)] was assessed. The false discovery rate (FDR) method was used to correct for multiple comparisons. No significant differences in terms of CBF and CVR were found between PD patients and HCs. Positive significant correlations were observed between CBF and UPDRS III within the precentral gyrus, postcentral gyrus, supplementary motor area, striatum, pallidum, thalamus, red nucleus, and substantia nigra (pFDR < 0.05). Conversely, significant negative correlation between CVR and UPDRS III was found in the corpus striatum (pFDR < 0.05). CBF and CVR assessment provides information about NVU integrity in an indirect and noninvasive way. Our findings support the hypothesis of NVU involvement at the mild to moderate stages of PD, suggesting that CBF and CVR within the motor network might be used as either diagnostic or prognostic markers for PD.
Sections du résumé
BACKGROUND
BACKGROUND
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is mainly characterized by movement dysfunction. Neurovascular unit (NVU) disruption has been proposed to be involved in the disease, but its role in PD neurodegenerative mechanisms is still unclear. The aim of this study was to investigate cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) within the regions belonging to the motor network, in patients with mild to moderate stages of PD.
METHODS
METHODS
Twenty-eight PD patients (66.6 ± 8.6 years, 22 males, median [interquartile range, IQR] Hoehn & Yahr = 1.5 [1-1.9]) and 32 age- and sex-matched healthy controls (HCs) were scanned with arterial spin labeling (ASL) magnetic resonance imaging (MRI) for CBF assessment. ASL MRI was also acquired in hypercapnic conditions to induce vasodilation and subsequently allow for CVR measurement in a subgroup of 13 PD patients and 13 HCs. Median CBF and CVR were extracted from cortical and subcortical regions belonging to the motor network and compared between PD patients and HCs. In addition, the correlation between these parameters and the severity of PD motor symptoms [quantified with Unified Parkinson's Disease Rating Scale part III (UPDRS III)] was assessed. The false discovery rate (FDR) method was used to correct for multiple comparisons.
RESULTS
RESULTS
No significant differences in terms of CBF and CVR were found between PD patients and HCs. Positive significant correlations were observed between CBF and UPDRS III within the precentral gyrus, postcentral gyrus, supplementary motor area, striatum, pallidum, thalamus, red nucleus, and substantia nigra (pFDR < 0.05). Conversely, significant negative correlation between CVR and UPDRS III was found in the corpus striatum (pFDR < 0.05).
CONCLUSION
CONCLUSIONS
CBF and CVR assessment provides information about NVU integrity in an indirect and noninvasive way. Our findings support the hypothesis of NVU involvement at the mild to moderate stages of PD, suggesting that CBF and CVR within the motor network might be used as either diagnostic or prognostic markers for PD.
Identifiants
pubmed: 30923574
doi: 10.1177/1756286419838354
pii: 10.1177_1756286419838354
pmc: PMC6431769
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1756286419838354Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declare that there is no conflict of interest.
Références
J Neurol Sci. 2001 Dec 15;193(1):29-36
pubmed: 11718747
Neuroimage. 2002 Sep;17(1):479-89
pubmed: 12482100
Mov Disord. 2004 Sep;19(9):1020-8
pubmed: 15372591
J Neural Transm (Vienna). 2005 Sep;112(9):1237-48
pubmed: 15666038
Ann Neurol. 2005 Feb;57(2):176-9
pubmed: 15668963
Parkinsonism Relat Disord. 2005 Jun;11(4):227-32
pubmed: 15878583
Am J Psychiatry. 2005 Jul;162(7):1256-65
pubmed: 15994707
Trends Neurosci. 1990 Jul;13(7):266-71
pubmed: 1695401
Neuroimage. 2007 Mar;35(1):222-33
pubmed: 17223579
Brain Res. 2007 May 25;1147:265-71
pubmed: 17368575
Neurobiol Aging. 2011 Jan;32(1):115-24
pubmed: 19188005
Hum Brain Mapp. 2010 Dec;31(12):1886-99
pubmed: 20162604
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Brain. 2011 Mar;134(Pt 3):845-55
pubmed: 21310726
Neuroradiology. 2012 Mar;54(3):261-8
pubmed: 21927866
Hum Brain Mapp. 2012 Dec;33(12):2802-14
pubmed: 21976406
Mov Disord. 2013 Apr;28(4):469-75
pubmed: 23238963
Lancet Neurol. 2013 Jul;12(7):716-26
pubmed: 23769598
PLoS One. 2013 Jun 25;8(6):e66834
pubmed: 23825570
Mov Disord. 2013 Sep;28(10):1337-42
pubmed: 23925977
Neuroimage Clin. 2013 Jul 06;3:1-7
pubmed: 24159561
Front Physiol. 2014 Mar 28;5:114
pubmed: 24734023
Int J Comput Assist Radiol Surg. 2015 Mar;10(3):329-41
pubmed: 24841147
J Neurol. 2014 Aug;261(8):1628-35
pubmed: 24920492
JAMA Neurol. 2014 Oct;71(10):1275-81
pubmed: 25133874
Neurol Sci. 2015 Feb;36(2):209-14
pubmed: 25139107
Exp Neurol. 2014 Nov;261:720-32
pubmed: 25160895
Neuroimage Clin. 2014 Aug 01;6:1-8
pubmed: 25379411
Neurobiol Dis. 2015 Feb;74:392-405
pubmed: 25533682
J Cereb Blood Flow Metab. 2015 May;35(5):747-50
pubmed: 25757748
Mov Disord. 2015 Dec;30(14):1893-900
pubmed: 25759166
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Parkinsons Dis. 2015;2015:523041
pubmed: 26167330
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Neurol Neurochir Pol. 2016 Nov - Dec;50(6):455-462
pubmed: 27553189
J Neural Transm (Vienna). 2017 May;124(5):551-557
pubmed: 28271290
NPJ Parkinsons Dis. 2016 Dec 01;2:16025
pubmed: 28725705
Neuroimage. 2019 Feb 15;187:192-208
pubmed: 29031532
Nat Rev Neurol. 2018 Mar;14(3):133-150
pubmed: 29377008
Parkinsonism Relat Disord. 2018 May;50:61-68
pubmed: 29449186
Ultrastruct Pathol. 2018 Mar-Apr;42(2):181-192
pubmed: 29466086
Brain Imaging Behav. 2018 May 9;:
pubmed: 29744796
Rev Neurol (Paris). 2018 Dec;174(10):699-704
pubmed: 30131173
Science. 2018 Sep 7;361(6406):975-976
pubmed: 30190391